Integrated Photoacoustic and Fluorescence Confocal Microscopy by Wang, Yu et al.
2576 IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 57, NO. 10, OCTOBER 2010
Integrated Photoacoustic and Fluorescence
Confocal Microscopy
Yu Wang, Konstantin Maslov, Chulhong Kim, Song Hu, and Lihong V. Wang*, Fellow, IEEE
Abstract—We have developed a dual-modality imaging system
by integrating optical-resolution photoacoustic microscopy and flu-
orescence confocal microscopy to provide optical absorption and
fluorescence contrasts simultaneously. By sharing the same laser
source and objective lens, intrinsically registered photoacoustic
and fluorescence images are acquired in a single scan. The microm-
eter resolution allows imaging of both blood and lymphatic vessels
down to the capillary level. Simultaneous photoacoustic angiogra-
phy and fluorescence lymphangiography were demonstrated, pre-
senting more information to study tumor angiogenesis, vasculature,
and microenvironments in vivo.
Index Terms—Angiography, fluorescence confocal microscopy
(FCM), lymphangiography, multimodal imaging, photoacoustic
microscopy (PAM).
I. INTRODUCTION
MULTIMODAL imaging provides complementaryanatomical and functional contrasts of biological
tissue. Predominantly sensitive to optical-absorption contrast,
photoacoustic microscopy (PAM) can noninvasively image both
hemoglobin concentration and oxygen saturation in single blood
vessels using endogenous contrast [1], [2]. Such functional
contrasts have been coregistered with anatomical contrasts by
combining PA imaging with other imaging modalities, such as
optical coherence tomography (OCT) [3], [4], backscattering
confocal microscopy (BCM) [5], and ultrasonic imaging
(USI) [6], [7]. While OCT and BCM image optical scattering,
USI senses acoustic scattering. Anatomical images based on
such scattering contrasts provide rich context for the functional
PA images. Here, we report a hybrid PA and fluorescence con-
focal microscopy (PA-FCM). FCM has already been applied in
a broad variety of biological studies for imaging fluorophores.
We believe that our new hybrid imaging system can offer more
comprehensive insights into physiology through coregistered
microscopic images of optical absorption and fluorescence
contrasts.
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Fig. 1. Schematic of the dual-modality PA-FCM system.
To demonstrate the PA-FCM system, we imaged blood ves-
sels and draining lymphatic vessels in vivo simultaneously.
In vivo angiography and lymphangiography are invaluable in
microvascular-related physiological and pathophysiological re-
search [8], [9]. Cancer hallmarks include hypoxia, angiogenesis,
and lymphangiogenesis [10]–[12]. Moreover, cancer metastases
can occur via blood or lymphatic vessels. Spectroscopic PA
imaging has been employed to study new blood vessel formation
and hemoglobin oxygen saturation (SO2) in tumors [13], [14].
Meanwhile, fluorescence microscopy has been widely used to
image lymphangiogenesis and lymphatic hyperplasia in mouse-
tumor models [15]. The combination of PA angiography and
fluorescence lymphangiography can provide more comprehen-
sive information for monitoring tumor growth and treatment in
small animals.
II. METHODS AND MATERIALS
A. PA-FCM System
Fig. 1 illustrates the experimental configuration of our PA-
FCM system. The optical-resolution PAM subsystem was de-
scribed in detail previously [1]. Briefly speaking, a tunable dye
laser (Pyrromethene 597, Exciton, CBR-D, Sirah) pumped by
a Nd:YLF laser (INNOSLAB, Edgewave) serves as the irradia-
tion source. The laser beam (pulse duration, 7 ns), after passing
through the excitation pinhole (pinhole diameter, 25 µm), is
focused into the sample by an objective lens (NA, 0.2; magnifi-
cation, 13.3). The laser pulse energy after the objective lens is
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∼100 nJ. The generated PA waves are reflected by an acoustic-
optical beam splitter to a 75-MHz ultrasonic transducer (V2022
BC, Olympus NDT). The FCM subsystem shares the same ob-
jective lens. A dichroic mirror (DMLP605, Thorlabs) allows
transmission of fluorescence (above 605 nm) emitted from the
sample. Two emission filters (FF01–624/40–25, Semrock) fur-
ther eliminate the reflected excitation light. The fluorescence
light passing through the detection pinhole (pinhole diameter,
50 µm) is collected by a photomultiplier tube module (H6780–
20, Hamamatsu). The diameter of the detection pinhole was cho-
sen by approximately matching the object-side pinhole diameter
(detection pinhole diameter divided by objective lens magnifi-
cation = 3.8 µm) with one Airy unit (1.22 λ/NA = 3.5 µm).
This method is commonly used in FCM to improve SNRs, while
sufficiently rejecting light from off-focus plane [16], [17]. The
amplified PA and fluorescence signals are digitized by a data-
acquisition card (CS 14200, Gage Applied). Two-dimensional
raster scanning of the sample along the x–y transverse plane pro-
vides automatically coregistered PA and fluorescence images.
Dual-wavelength angiography and lymphangiography images
are captured by changing the laser wavelength after complet-
ing each B-scan. For light-fluence compensation for both PA
and fluorescence images, the laser energy is measured at both
wavelengths by a photodiode before imaging.
B. Animal Preparation
We applied the multimodal system to image an ear of a nude
mouse (Harlan, body weight ∼20 g) in vivo. To visualize the
lymphatic network using PA-FCM, 5 µL of 20% rhodamine B
isothiocyanate (RITC)–dextran (R9379, Sigma; average molec-
ular weight ∼70 000) was injected into the mouse’s ear tip
using a 29-gauge needle. Imaging of blood and lymphatic ves-
sels started immediately after the dye injection and lasted for
∼40 min. To keep the animal motionless, a breathing anesthesia
system (E-Z Anesthesia, Euthanex) ventilated a gas mixture of
1% isoflurane and medical grade oxygen to the mouse during
experiments. All experimental animal procedures were carried
out in conformity with the laboratory protocol approved by
the Animal Studies Committee of the School of Medicine at
Washington University in St. Louis.
III. RESULTS
A. Spatial Resolution of PA-FCM System
The spatial resolution of the PA-FCM system was measured
experimentally. To quantify the resolution of PAM, a surgical
blade was used as the sample. Fig. 2(a) shows the edge-spread
function from the blade PAM image. The measured edge-spread
function was nonlinearly fitted by an error function. The full
width at half maximum (FWHM) of its derivative—defining
the lateral resolution—was estimated to be ∼3.9 µm. The ax-
ial resolution of PAM was measured using a “shift-and-sum”
method with a single A-line PA signal in Fig. 2(b) [18]. The
estimated PAM axial resolution was∼17 µm, as determined by
the 100-MHz bandwidth of the transducer. We quantified the
resolution of confocal microscopy by measuring reflected light
Fig. 2. Spatial resolutions of the dual-modality PA-FCM. (a) Lateral edge-
spread function of the PAM. (b) Axial resolution of the PAM. (c) Lateral edge-
spread function of the confocal microscope. (d) Axial resolution of the confocal
microscope.
from a cracked silver-mirror surface. Emission filters were re-
moved for the resolution test. The edge-spread function of the
confocal microscope, as plotted in Fig. 2(c), yielded a lateral
resolution of ∼3.9 µm. To measure the axial resolution of the
confocal microscope, the mirror was translated along the axial
direction. Fig. 2(d) plots the normalized reflected light inten-
sity with the mirror surface at various depths. The experimental
data was then fitted by a (sinc)4 function [16], whose FWHM
of ∼38 µm was used as the axial resolution of the confocal
microscope.
B. Vascular and Lymphatic Imagings
Anatomical and functional images of a nude mouse ear were
acquired at dual wavelengths (570 and 593 nm). Fig. 3(a) shows
a structural PA image of vasculatures in the ear taken at an op-
tical wavelength of 570 nm. Because 570 nm is an isosbestic
point of oxyhemoglobin (HbO2) and deoxyhemoglobin (HbR)
molar absorptivities, the PA signal amplitude measured at this
wavelength depends on the total hemoglobin (HbT) concentra-
tion but not the SO2 . Aided by the PA-FCM images acquired at
593 nm, the relative concentrations of HbO2 and HbR, and sub-
sequently SO2 , can be calculated based on the molar extinction
spectra of HbO2 and HbR [9]. The PA SO2 mapping is shown in
Fig. 3(b). Fig. 3(c) shows the fluorescence images of lymphatics
obtained simultaneously with the PA image in Fig. 3(a). After
injection of RITC-dextran, lymphatic networks became visible
in the FCM image. The mean ratio of the fluorescence sig-
nals from the lymphatic network at the excitation wavelengths
of 570 and 593 nm was 9.2, and the ratio measured with the
fluorescence dye in vitro was 10.0, confirming fluores-
cence emission from RITC-dextran. Fig. 3(d) coregisters the
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Fig. 3. Combined functional vascular and lymphatic images of a mouse ear
in vivo. (a) PAM image of microvasculature acquired at 570 nm. (b) PA SO2
mapping based on dual-wavelength (570 and 593 nm) measurements. (c) FCM
image of the lymphatic system acquired at 570 nm after the injection of 20%
RITC-dextran. (d) Fused mapping of total hemoglobin concentration and flu-
orescent lymphatics. (e) Fused mapping of SO2 and fluorescent lymphatics.
(f) Optical microscopic image acquired within the same region. FL: fluores-
cence. OM: optical microscopy.
mappings of the total hemoglobin concentration and fluores-
cence lymphatics. Fig. 3(e), the fused image of vessel-by-
vessel SO2 and fluorescent lymphatics, clearly depicts arteri-
oles, venules, and draining lymphatic vessels in the mouse ear.
Because vasculature regulates the metabolic and hemodynamic
states of biological tissue and angiogenesis and lymphangio-
genesis facilitate the spread of cancer, visualizing both blood
and lymphatic vessels enables more comprehensive tracking of
cancer metastasis.
IV. CONCLUSION
The experimental results here demonstrate the capability of
the PA-FCM system in revealing complementary PA and flu-
orescence contrasts. The applications of PA-FCM will not be
limited to the fusion of angiography and lymphangiography.
Fluorescent molecular probes for tumor detection can be used
so that tumor location and angiogenesis can be visualized simul-
taneously. With voltage-sensitive dye, fluorescence imaging can
map voltage changes of the cell membrane potential [19]; while
PAM can image the vasoconstriction and vasodilatation of blood
vessels [2]. Hence, the PA-FCM system may be used to image
neurovascular interactions during brain electrical stimulation.
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